ALEMBIC PHARMA Fact Sheet, ALEMBIC PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Fact Sheet   (APLL)


Find Out: How to Find One Stock with Crorepati Potential?


Here is the latest financial fact sheet of ALEMBIC PHARMA. For more details, see the ALEMBIC PHARMA quarterly results and ALEMBIC PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALEMBIC PHARMA Price History

Price Rs 726.1
Mkt Cap Rs m 142,724
Vol '000 1.7
P/E X 27.7
P/CF X 11.0
EPS (TTM) Rs 26.2
1 Day % 0.2
No. of shares m 196.56
1 Week % 0.1
1 Month % -4.5
1 Year % -26.0
52 week H/L Rs 1,015.9/672.0
As on Jun 24, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALEMBIC PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
ALEMBIC PHARMA EQUITY SHARE DATA
High Rs7096456646831,150 
Low Rs516470412435527 
Sales per share (Unadj.) Rs166.3166.1208.7244.3274.4 
Earnings per share (Unadj.) Rs21.622.331.442.556.7 
Diluted earnings per shareRs20.721.430.140.756.7 
Cash flow per share (Unadj.) Rs26.027.937.550.866.0 
Dividends per share (Unadj.) Rs4.004.005.5010.0014.00 
Adj. dividends per shareRs3.843.845.279.5914.00 
Avg Dividend yield %0.70.71.01.81.7 
Book value per share (Unadj.) Rs100.9117.8144.2170.8260.9 
Adj. book value per shareRs96.8112.9138.3163.8260.9 
Shares outstanding (eoy) m188.52188.52188.52188.52196.56 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x3.73.42.62.33.1 
Avg P/E ratio x28.425.017.113.214.8 
P/CF ratio (eoy) x23.620.014.311.012.7 
Price / Book Value ratio x6.14.73.73.33.2 
Dividend payout %18.517.917.523.524.7 
Avg Mkt Cap Rs m115,452105,079101,459105,343164,818 
No. of employees `000NANANANANA 
Total wages/salary Rs m5,5886,2287,4679,06410,512 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
ALEMBIC PHARMA INCOME DATA
Net Sales Rs m31,34631,30839,34746,05853,931 
Other income Rs m26349271139875 
Total revenues Rs m31,37231,65739,61846,19654,806 
Gross profit Rs m6,1476,1538,55811,70414,801 
Depreciation Rs m8301,0551,1521,5731,835 
Interest Rs m5234184272160 
Profit before tax Rs m5,2915,4137,4939,99813,681 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,2221,2041,5681,9922,533 
Profit after tax Rs m4,0694,2095,9268,00611,148 
Gross profit margin %19.619.721.825.427.4 
Effective tax rate %23.122.220.919.918.5 
Net profit margin %13.013.415.117.420.7 
ALEMBIC PHARMA BALANCE SHEET DATA
Current assets Rs m14,93819,47521,31724,62825,779 
Current liabilities Rs m8,14012,67216,63717,51612,808 
Net working cap to sales %21.721.711.915.424.1 
Current ratio x1.81.51.31.42.0 
Inventory Days Days1413101023 
Debtors Days Days46572 
Net fixed assets Rs m13,16821,16328,20035,26341,311 
Share capital Rs m377377377377393 
"Free" reserves Rs m18,64621,82426,81131,81750,883 
Net worth Rs m19,02322,20127,18832,19451,276 
Long term debt Rs m05,0004,9938,8701,999 
Total assets Rs m28,10640,63849,51859,89167,090 
Interest coverage x102.2160.241.737.886.4 
Debt to equity ratio x00.20.20.30 
Sales to assets ratio x1.10.80.80.80.8 
Return on assets %14.710.412.313.816.9 
Return on equity %21.419.021.824.921.7 
Return on capital %28.120.023.925.026.0 
Exports to sales %49.846.449.447.366.8 
Imports to sales %10.310.515.413.212.7 
Exports (fob) Rs m15,62614,53519,45321,80836,020 
Imports (cif) Rs m3,2413,2886,0656,0626,845 
Fx inflow Rs m15,80614,72219,45321,80836,020 
Fx outflow Rs m5,2897,0266,0656,0626,845 
Net fx Rs m10,5177,69613,38815,74629,175 
ALEMBIC PHARMA CASH FLOW
From Operations Rs m 3,286 3,124 8,120 4,492 14,634 
From Investments Rs m -4,859 -8,844 -7,556 -7,316 -8,388 
From Financial Activity Rs m -1,289 5,026 590 1,549 -5,974 
Net Cashflow Rs m -2,862 -693 1,153 -1,272 262 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 69.6%
Institution 17.8%
Non-Institution 12.6%
Total 100.0%
Free Float 30.4%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off Alembic Road, Vadodara - 390003
E-mail apl.investors@alembic.co.in Web www.alembicpharmaceuticals.com
Tel 0265 - 2280550 2280880 Fax 0265 - 2282506
Sector PHARMACEUTICALS Group Alembic Group
Tr Agent Link Intime India Pvt Ltd., B-102 & B103 Shangrila Complex First Floor, Opp: HDFC Bank Near Radhakrishna Char Rasta, Akota
Auditor K. S. Aiyar & Co.
CHM: Chirayu Amin COMP SEC: Charandeep Singh Saluja YEAR OF INC: 2010 BSE CODE: 533573 FV (Rs): 2 DIV YIELD (%): 1.9

Read: ALEMBIC PHARMA 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare ALEMBIC PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    


Yellow Ad

Advertisement

A One Stock Gift in 1990 Turns into Rs 130 Crores

In 2017, Ravi made headlines by calling a leading business news channel with a surprising announcement - his grandfather had left him 20,000 shares of only one stock.

And on the day of his call - these shares were worth Rs 130 crore.

Can you guess which is this company?

It's MRF.

Ravi's story is one of the amazing stories of becoming Crorepati from a single stock.

But the question is, how to find that one stock with crorepati potential?

To find the answer to this million-dollar question, join our 'One Stock Crorepati' MEGA summit on 30th June, where we will reveal details of what we call a potential 'crorepati' stock...

Learn more



Today's Market

Sensex Zooms 462 Points, Nifty Ends Near 15,700; Auto & FMCG Stocks Rally(Closing)

Indian share markets ended the week on a firm note tracking positive global cues.

Views on news

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks (Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Why Tata Power Share Price is Falling (Views On News)

Jun 14, 2022

Here's why shares of Tata Power have fallen in recent days.

Is it Time to Start Buying Stocks Selectively? (Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

Best Monopoly Stocks to Own in 2022 Views On News (Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

When Will the Stock Market Recover? (Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS